203 related articles for article (PubMed ID: 18299245)
21. Zac1 functional interactions mediate AP-1 transcriptional activity.
Wang WM; Liu ST; Huang SM; Lin WS; Chen SG; Chang YL
Biochim Biophys Acta; 2011 Dec; 1813(12):2050-60. PubMed ID: 21864583
[TBL] [Abstract][Full Text] [Related]
22. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
[TBL] [Abstract][Full Text] [Related]
23. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
24. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
Wiseman A
Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
[TBL] [Abstract][Full Text] [Related]
25. ZAC1 target genes and pituitary tumorigenesis.
Theodoropoulou M; Stalla GK; Spengler D
Mol Cell Endocrinol; 2010 Sep; 326(1-2):60-5. PubMed ID: 20117169
[TBL] [Abstract][Full Text] [Related]
26. Difference in the centrosome duplication regulatory activity among p53 'hot spot' mutants: potential role of Ser 315 phosphorylation-dependent centrosome binding of p53.
Tarapore P; Tokuyama Y; Horn HF; Fukasawa K
Oncogene; 2001 Oct; 20(47):6851-63. PubMed ID: 11687964
[TBL] [Abstract][Full Text] [Related]
27. Zac1 is up-regulated in neural cells of the limbic system of mouse brain following seizures that provoke strong cell activation.
Valente T; Domínguez MI; Bellmann A; Journot L; Ferrer I; Auladell C
Neuroscience; 2004; 128(2):323-36. PubMed ID: 15350644
[TBL] [Abstract][Full Text] [Related]
28. TOE1 interacts with p53 to modulate its transactivation potential.
Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
[TBL] [Abstract][Full Text] [Related]
29. p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation.
Asefa B; Dermott JM; Kaldis P; Stefanisko K; Garfinkel DJ; Keller JR
FEBS Lett; 2006 Feb; 580(5):1205-14. PubMed ID: 16458891
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation of p53 by Pitx1.
Liu DX; Lobie PE
Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2.
Kong HJ; Park MJ; Hong S; Yu HJ; Lee YC; Choi YH; Cheong J
Hepatology; 2003 Nov; 38(5):1258-66. PubMed ID: 14578865
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone-mediated negative transcriptional regulation of Necdin expression.
Nygård M; Becker N; Demeneix B; Pettersson K; Bondesson M
J Mol Endocrinol; 2006 Jun; 36(3):517-30. PubMed ID: 16720720
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.
Poirier MB; Laflamme L; Langlois MF
J Mol Endocrinol; 2006 Apr; 36(2):313-25. PubMed ID: 16595702
[TBL] [Abstract][Full Text] [Related]
34. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
[TBL] [Abstract][Full Text] [Related]
35. Nuclear localization signal of ING4 plays a key role in its binding to p53.
Zhang X; Wang KS; Wang ZQ; Xu LS; Wang QW; Chen F; Wei DZ; Han ZG
Biochem Biophys Res Commun; 2005 Jun; 331(4):1032-8. PubMed ID: 15882981
[TBL] [Abstract][Full Text] [Related]
36. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
Shiseki M; Nagashima M; Pedeux RM; Kitahama-Shiseki M; Miura K; Okamura S; Onogi H; Higashimoto Y; Appella E; Yokota J; Harris CC
Cancer Res; 2003 May; 63(10):2373-8. PubMed ID: 12750254
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
[TBL] [Abstract][Full Text] [Related]
38. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
39. Function of the ING family of PHD proteins in cancer.
Gong W; Suzuki K; Russell M; Riabowol K
Int J Biochem Cell Biol; 2005 May; 37(5):1054-65. PubMed ID: 15743678
[TBL] [Abstract][Full Text] [Related]
40. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.
Cano CE; Gommeaux J; Pietri S; Culcasi M; Garcia S; Seux M; Barelier S; Vasseur S; Spoto RP; Pébusque MJ; Dusetti NJ; Iovanna JL; Carrier A
Cancer Res; 2009 Jan; 69(1):219-26. PubMed ID: 19118006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
